Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Takuji NAKANO"'
Autor:
Teiji Kuzuya, Naoto Kawabe, Hisanori Muto, Yoshihiko Tachi, Takeshi Ukai, Yuryo Wada, Gakushi Komura, Takuji Nakano, Hiroyuki Tanaka, Kazunori Nakaoka, Eizaburo Ohno, Kohei Funasaka, Mitsuo Nagasaka, Ryoji Miyahara, Yoshiki Hirooka
Publikováno v:
Current Oncology, Vol 31, Iss 10, Pp 6218-6231 (2024)
Aim: To investigate the characteristics and prognosis of patients with advanced hepatocellular carcinoma (HCC) treated with atezolizumab and bevacizumab (Atz/Bev) who achieved a complete response (CR) according to the modified Response Evaluation Cri
Externí odkaz:
https://doaj.org/article/ce984f5634b444c5b2874a12ef5b454f
Autor:
Teiji Kuzuya, Naoto Kawabe, Hisanori Muto, Yuryo Wada, Gakushi Komura, Takuji Nakano, Hiroyuki Tanaka, Kazunori Nakaoka, Eizaburo Ohno, Kohei Funasaka, Mitsuo Nagasaka, Ryoji Miyahara, Yoshiki Hirooka
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4225-4240 (2024)
The relationship between antitumor response and tumor marker changes was evaluated in patients with advanced hepatocellular carcinoma treated with durvalumab plus tremelimumab (Dur/Tre). Forty patients were enrolled in this retrospective evaluation o
Externí odkaz:
https://doaj.org/article/2b449c6a49b64eebb72209e1b4056043
Autor:
Kazunori Nakaoka, Senju Hashimoto, Naoto Kawabe, Teiji Kuzuya, Hiroyuki Tanaka, Takuji Nakano, Yuichiro Uchida, Yohei Miyachi, Kohei Funasaka, Mitsuo Nagasaka, Yoshihito Nakagawa, Takeshi Takahara, Ryoji Miyahara, Tomoyuki Shibata, Tetsuya Tsukamoto, Koichi Suda, Yoshiki Hirooka
Publikováno v:
DEN Open, Vol 3, Iss 1, Pp n/a-n/a (2023)
Abstract The diagnosis of bile duct tumors can be difficult at times. A transpapillary bile duct biopsy findings with endoscopic retrograde cholangiopancreatography sometimes contradict diagnostic imaging findings. In bile duct tumors, inflammatory p
Externí odkaz:
https://doaj.org/article/80a675cda78645cc901f1ef00cd3205b
Publikováno v:
JGH Open, Vol 5, Iss 6, Pp 705-711 (2021)
Abstract Background and Aim This study investigated the efficacy of transcatheter arterial infusion (TAI) chemotherapy with cisplatin combined with transcatheter arterial chemoembolization (TACE). The goal was to prevent intrahepatic distant recurren
Externí odkaz:
https://doaj.org/article/01c96e9cfb114c60bbf9b15766ad62b2
Autor:
Kazunori Nakaoka, Senju Hashimoto, Naoto Kawabe, Takuji Nakano, Toshiki Kan, Masashi Ohki, Yuka Ochi, Tomoki Takamura, Takamitsu Kurashita, Sayuri Nomura, Keishi Koyama, Aiko Fukui, Kentaro Yoshioka
Publikováno v:
Endoscopy International Open, Vol 06, Iss 10, Pp E1164-E1170 (2018)
Background and study aims Biliary metallic stents are used to drain unresectable malignant distal biliary obstructions. This study aimed to evaluate the efficacy of a novel 12-mm-diameter covered, self-expandable end bare metal stent (12-mm CSEEMS).
Externí odkaz:
https://doaj.org/article/11a996d1bba048b4968adca4d9655157
Publikováno v:
Journal of Japan Society on Water Environment. 46:21-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e458ade277fdd3d0ee0961e6856c3da
https://doi.org/10.2965/jswe.46.21
https://doi.org/10.2965/jswe.46.21
Autor:
Kazunori Nakaoka, Senju Hashimoto, Naoto Kawabe, Teiji Kuzuya, Hiroyuki Tanaka, Takuji Nakano, Yuichiro Uchida, Yohei Miyachi, Kohei Funasaka, Mitsuo Nagasaka, Yoshihito Nakagawa, Takeshi Takahara, Ryoji Miyahara, Tomoyuki Shibata, Tetsuya Tsukamoto, Koichi Suda, Yoshiki Hirooka
Publikováno v:
DEN Open. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2a5814f23fa06ad3c4aedda8f4780e8
https://doi.org/10.1002/deo2.143
https://doi.org/10.1002/deo2.143
Publikováno v:
JGH Open, Vol 5, Iss 6, Pp 705-711 (2021)
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
Background and Aim This study investigated the efficacy of transcatheter arterial infusion (TAI) chemotherapy with cisplatin combined with transcatheter arterial chemoembolization (TACE). The goal was to prevent intrahepatic distant recurrence (IDR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e87309891e7646d4474c094c9116b2b
https://doaj.org/article/01c96e9cfb114c60bbf9b15766ad62b2
https://doaj.org/article/01c96e9cfb114c60bbf9b15766ad62b2
Autor:
Akira Sawaki, Teiji Kuzuya, Ryoji Miyahara, Atsushi Sugioka, Arisa Mii, Takuji Nakano, Yoshiki Hirooka, Naoto Kawabe, Kazunori Nakaoka, Yohei Miyachi, Hiroyuki Tanaka, Sayaka Kamejima, Takeshi Takahara, Yutaro Kato, Senju Hashimoto
Publikováno v:
Oncology. 100(1)
Introduction: The aim of this study was to investigate the early changes in alpha-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP) levels in patients with advanced hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f01d83b3f51478c6bb58f52eb5b05f3f
https://pubmed.ncbi.nlm.nih.gov/34731863
https://pubmed.ncbi.nlm.nih.gov/34731863
Autor:
Arisa Mii, Kazunori Nakaoka, Yoshiki Hirooka, Teiji Kuzuya, Naoto Kawabe, Atsushi Sugioka, Takuji Nakano, Hiroyuki Tanaka, Yohei Miyachi, Senju Hashimoto, Yoshinao Tanahashi, Yutaro Kato, Ryoji Miyahara
Publikováno v:
Cancer Diagn Progn
Background/Aim: The aim of this study was to investigate the outcomes of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma (HCC), including those with disease refractory to lenvatinib, in clinical practice. Patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f08b4856aa5e2af2e9076ece1b5d26b
https://europepmc.org/articles/PMC8962759/
https://europepmc.org/articles/PMC8962759/
